Onicor is focused on transforming the treatment of onychomycosis, a common yet often undertreated condition affecting millions worldwide. Despite its high prevalence, current treatment options remain limited by long treatment durations, suboptimal cure rates, systemic side effects, or poor patient adherence. Onicor is building a new generation of targeted, patient-friendly solutions designed to overcome these limitations and meaningfully improve clinical outcomes.

Our approach centers on combining scientific rigor with practical usability. Onicor aims to create treatments that are more effective, safer, and easier for patients to complete. We believe that innovation in this space must address not only fungal eradication but also convenience, comfort, and real-world compliance.

Beyond clinical impact, our mission is to restore confidence and quality of life for patients affected by nail fungal infections. Onicor envisions a future where onychomycosis can be treated reliably, safely, and without the frustration associated with today’s therapies. By addressing a large, underserved market with innovative technology and patient-centered design, Onicor is positioned to redefine the standard of care in nail antifungal treatment.